Evidence map›Paper›PMID 42873820›Full record

ArticlePLoS pathogens2026

Intranasal HSV‑1 infection drives region‑specific interferon‑dominant microglial remodeling.

Seth Frietze, Cameron Lunn, Dean Oldham, Joseph R Boyd, Andrew N Bubak, Amalia Bustillos Saucedo, Maria A Nagel, Diego Restrepo, Kimberley D Bruce, Christy S Niemeyer

Abstract read
PubMed Publisher
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Seth FrietzeDepartment of Biomedical and Health Sciences, University of Vermont, Burlington, Vermont, United States of America.
Cameron LunnDepartment of Biomedical and Health Sciences, University of Vermont, Burlington, Vermont, United States of America.
Dean OldhamDivision of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Joseph R BoydDepartment of Biomedical and Health Sciences, University of Vermont, Burlington, Vermont, United States of America.
Andrew N BubakDepartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Amalia Bustillos SaucedoDepartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Maria A NagelDepartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Diego RestrepoDepartment of Physiology and Biophysics, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, United States of America.
Kimberley D BruceDivision of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Christy S NiemeyerDepartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.ORCID https://orcid.org/0000-0001-6830-6522

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herpes simplex virus type 1 (HSV-1) is a neurotropic pathogen capable of invading the central nervous system (CNS) and is associated with chronic neuroinflammation, cognitive impairment, and neurodegenerative disease. While microglia orchestrate the initial immune response to HSV‑1, the molecular mechanisms that regulate their sustained neuroinflammatory activity in vivo remain poorly understood. To define the transcriptional and epigenetic mechanisms that shape microglial responses during acute HSV-1 infection in vivo, we have, for the first time, integrated single‑nucleus RNA sequencing, chromatin accessibility profiling, and spatial proteomics and transcriptomics in an intranasal HSV‑1 infection model. Single-cell multiome analysis of CD11b⁺ nuclei identified transcriptionally and epigenetically distinct microglial and macrophage populations. HSV-1 infection redistributed monocyte-lineage states, with a marked overrepresentation of interferon (IFN)‑responsive microglia and macrophage-associated populations characterized by amplification of Stat1/2, Irf1, and Cebpb rather than reflecting uniform inflammatory activation. In parallel, homeostatic microglial gene signatures (e.g., ApoE, Cst3) were reduced following HSV-1 infection. Spatial transcriptomics localized HSV‑1 antigen to discrete brainstem regions, which were enriched for predicted STAT1/2, IRF1, and CEBPB‑regulated targets identified through single‑nuclei analysis, demonstrating that these inferred transcriptional networks are activated within anatomically defined regions in vivo. Complementary spatial proteomics further confirmed increased microglial activation and astrocytic responses specifically within HSV-1 antigen-positive regions. Together, these integrated multiomic analyses demonstrate that HSV-1 induces localized transcriptional and epigenetic remodeling of microglia dominated by IFN-driven regulatory programs and a loss of homeostatic signatures. By linking single-cell regulatory architecture to spatially restricted tissue responses, our findings provide mechanistic insight into how localized viral infection sustains neuroinflammation, contributing to long-term neurological vulnerability and neurodegenerative disease risk.

Indexed as

Herpes SimplexHerpesvirus 1, HumanInterferonsMicrogliaAnimalsFemaleMacrophagesMiceMice, Inbred C57BLInterferons

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.